Morgan Stanley initiated coverage of Ryan Specialty (RYAN) with an Overweight rating and $90 price target The firm says a supportive pricing and macro environment is likely to persist for 2025 and beyond for the excess and surplus market, providing a tailwind for property and casualty companies that can demonstrate underwriting discipline and pricing power. The analyst prefers Kinsale, Ryan Specialty, and Brown & Brown in the group. Morgan Stanley expects pricing to remain supportive of growth in the excess and surplus market.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty Group Announces $500M Senior Notes Offering
- Ryan Specialty price target raised to $88 from $76 at Barclays
- Ryan Specialty Group Reports Robust Q3 2024 Performance
- Ryan Specialty in final talks to acquire Innovisk Capital
- Ryan Specialty maintains FY24 outlook for organic revenue growth at 13%-14%